2nd Global Pharmacovigilance & Adverse Event Reporting Conference Navigating Global Regulations and Reporting Requirements to Build Proactive Risk Management Strategies and Mitigate Potential Concerns By : marcus evans
Biomarkers World Europe New directions in drug discovery and development By : Health Network Communications
Exploratory Clinical Development World Europe 2012 Europe’s largest and most influential early development/phase I congress which will address the critical issues in achieving seamless first in man studies. By : Health Network Communications
Early Stage Clinical Development Minimize your drug attrition rates by improving translation from preclinical to clinical development By : Hanson Wade
6th Annual Licensing in Generics. Aiming to guarantee your excellence in deal making and expanding into today’s most attractive markets, we introduce to you our 6th Annual Licensing in Generics. By : Fleming Europe
Merging Multiple Drug Safety and Pharmacovigilance Databases into One Global Oracle Argus Safety System Leading provider of Oracle's clinical trial, data, and drug safety software will discuss a recent project for a top pharmaceutical company that entailed the merging of multiple drug safety systems. By : BioPharm Systems
ICH Q10 : Moving from GMPs to a Pharmaceutical Quality System This ICH Q10 training /webinar will discuss the evolution and interpretation of the pharmaceutical GMPs as a quality control regulation to the Quality Assurance emphasis of the Pharmaceutical Quality System as defined in ICH Q10. By : Compliance online
2nd Annual Orphan Drug Congress 2012 When orphan drugs are still at the stages of development, the latest and most accurate information is required for the drug to advance efficiently. Fleming Europe organizes the 2nd Annual Orphan Drug Congress 2012, where worldwide pharmaceutical experts will share their experiences and insight. By : Fleming Europe
Making All Data Count: FDA Acceptance of non-US Clinical Trials This webinar will help you understand how non-IND clinical trials at non-US locations can be used successfully to support an IND/IDE or a marketing approval application. By : Compliance online
Drug Pricing & Reimbursement, 6th Annual Forum Progressive Business, Legal and Regulatory Strategies to Increase Your Market Share By : The Canadian Institute
Global Pharma Manufacturing Summit 2012 Now in its seventh year, the Global Pharma Manufacturing Summit has grown into the premier networking opportunity for industry leaders involved in small molecule and biologic pharma manufacturing. By : World Trade Group
How To Establish An Effective Good Clinical Practice in Drugs and Medical Devices This webinar will help you establish an effective Good Clinical Practice (GCP) by providing a current, accurate and complete (CAC) review and applicable regulations for clinical trials or studies, the requirements and compliance in a systematic, integrative (SI) manner. By : Compliance online
World Vaccine Congress 2012 World Vaccine Congress Asia 2012 is the largest Asian vaccine conference which brings together the entire value chain of the vaccine industry. By : Terrapinn Pte Ltd
Pharma Excellence in the CEE, CIS, SEE & Turkey event CEE, CIS together with SEE and Turkey represent attractive arenas for pharma companies due to the wide availability of untreated patients, insufficient access to preventive medicine as well as lower costs. By : Fleming Europe
2-day In-person Seminar: Computer System Validation - Reduce Costs and Avoid 483s This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments. Attendees learn how to decrease software implementation times and lower costs using a 10-step risk-based approach. By : Compliance online
Laboratoires et CROs - Essais Cliniques 2010 Les meilleurs experts des laboratoires et CROs français et étrangers vous aideront à évaluer la performance de vos Essais Cliniques. Sécuriser vos dispositifs et augmenter la performance réglementaires de vos organisations face aux toutes dernières avancées. By : Development Institute International
Presentation from ADpredict blood biomarker Conference Biomarker Discovery and Validation: Challenges and Solutions It discuses the cutting-edge solutions in the application of biomarkers for drug discovery and personalised medicine. By : Richard Hadden Text 26 pages
Presentation from Biomarker Discovery Conference Biomarker Discovery and Validation: Challenges and Solutions It discuses the cutting-edge solutions in the application of biomarkers for drug discovery and personalised medicine. By : Stuard Blincko Text 12 pages
Presentation from Mining Mass Spectrometry Data for Biomarker Discovery Conference Biomarker Discovery and Validation: Challenges and Solutions It discuses the cutting-edge solutions in the application of biomarkers for drug discovery and personalised medicine. By : Conrad Bessant Text 14 pages
Presentation from Biomarkers for Drug Discovery Conference Biomarker Discovery and Validation: Challenges and Solutions It discuses the cutting-edge solutions in the application of biomarkers for drug discovery and personalised medicine. By : Gary R. Coulton Text 13 pages
Presentations from "The Peptide Conference 2010" conference The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Various Text 367 pages
Next-generation peptide microarrays The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Volker Stadler Text 27 pages
CIS display: an in-vitro display technology for the selection of therapeutic peptides & proteins The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Chris Ullman Text 45 pages
Modern concepts for solid phase synthesis The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Don Wellings Text 32 pages
Recent trends in large scale solid phase peptide synthesis The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Dr Eric Atheron Text 21 pages
Optimising antimicrobial peptides The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Dr David Ulaeto Text 34 pages
Clinical development of an oral formulation of recombinant salmon calcitonin The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Nozer Mehta Text 30 pages
Light scattering for protein and peptide characterisation The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Hanna Jankevics and Mark Pothecary Text 47 pages
Immunogenicity evaluation for therapeutic peptides The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Ingrid Marchal-Gérez Text 25 pages
Cell-penetrating peptides: enhancing the delivery of oligonucleotides & peptides by conjugation The Peptide Conference 2010 Conference covering the application of peptides in drug discovery and development.The applications of peptide chemistry from synthesis through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications from analytical to industrial scales were presented. By : Presented by Michael J. Gait Text 30 pages
Ensuring Integrity and Security of Electronic Records for FDA Compliance This seminar will discuss how to comply with FDA's ongoing Part 11 inspection program By : Labcompliance
Live webinar on Effective Root Cause Analysis and CAPA Program This webinar will highlight strategies to create a robust system of reporting and investigating deviations and other non-conforming events as part of an effective quality management system, as well as understand the regulatory requirements of corrective and preventive action system (CAPA) By : compliance2go
Live webinar on How to prepare for 510(k)s for in vitro diagnostic devices (IVDs) To expedite the process of bringing a product to market through the 510(k) program, it is imperative the medical device makers understand the recent changes and be able to prepare a 510(k) using a CAC-SI method. By : compliance2go
Live webinar on How to Prepare for FDA BIMO Inspections This webinar is intended to provide practical and actionable guidance on how to proactively prepare for a sustainable FDA Bioresearch Monitoring (BIMO) inspection and the proper response, if necessary, during and after the inspection including Do’s and Don’ts. By : compliance2go
Live webinar on Applying GMP Quality Principles To Establish A Reduced Testing Program As industry has been looking to reduce costs, improve efficiency, the FDA has begun to more closely scrutinize the industry’s effort to make certain that the above mentioned controls are in place. In this effort the FDA is focusing on supplier control and sampling issues. By : compliance2go
4th Vaccines China 2012 4th Vaccines China 2012 is timely and has been researched with the industry to provide the most comprehensive event focused on vaccines development through to manufacturing. Good manufacturing practices and strategies will be reviewed, alongside potential block-buster technologies and R&D projects. By : IBC Asia (S) Pte Ltd
Opinion Leader Development Join industry professionals at SMi's masterclass, Opinion Leader Development which is being led by The Central Group. By : SMi Group Ltd
World Drug Safety Congress Americas This meeting provides you with key insights into the drug safety challenges affecting you and gives you an excellent opportunity to discuss these diverse issues in a conference format. By : Health Network Communications
Creating and Managing Oracle Clinical, RDC, and TMS User Accounts with Ease Accel-Account Manager allows life sciences companies to easily and cost-effectively manage user accounts without technical knowledge. By : BioPharm Systems
Foreign Manufacturing Facilities – Avoiding Problems with FDA This 90-minute webinar on compliant foreign manufacturing facilities will help you understand the problems that can occur with foreign manufacturers of pharmaceuticals. Recent inspections and enforcement actions by FDA have brought the topic into greater focus. By : Compliance online
Pharmatec Japan 2012 PHARMATEC JAPAN is a new event dedicated to "Drug Packaging and Delivery Technology" for the pharmaceutical, biopharmaceutical, veterinary and medical industries in Japan By : Businesswise Communications
Late Phase Drug Development World Americas 2012 This meeting brings an extensive and diverse agenda, giving you everything you need to know about late phase.Hear from Pfizer, Novartis, AstraZeneca, Abbott, Eli Lilly & Co, Bayer and more! By : Health Network Communications
2nd Annual Pharma Packaging & Labelling Compliance Forum Anti-counterfeiting and packaging safely via redesign continues to be among the major themes of Fleming Europe’s 2nd Annual Pharma Packaging and Labelling Compliance Forum. By : Fleming Europe
Method Validation in Drug Development Process - Common Mistakes and Issues This Method Validation training in drug development process will provide guidance in setting appropriate specifications, determining if the assay is validatable, and monitoring progress during the validation. By : Compliance online
7th Annual Pricing, Reimbursement & Market Access in Pharma Fleming Europe invites you to the 7th Annual Pricing, Reimbursement & Market Access in Pharma. By : Fleming Europe